PATENT CLAIM ANALYSIS

Application Number: 15758405
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "578000"]

Abstract:
Disclosed herein are methods for treating, ameliorating, and/or preventing Alzheimer's Disease in a specific patient population using tramiprosate, valyl-3-amino-1-propanesulfonic acid, or a pharmaceutically acceptable salt thereof based upon a combination of APOE4 status and disease severity.

Claim (Index 4):
The method of  claim 3 , wherein the subject is APOE4 heterozygous and has moderate Alzheimer's disease as indicated by a baseline MMSE score of 16-19.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.13514
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15127565', '14399809', '14059529', '12738396', '13642845']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.4890051984648751
- 35 USC 102 Novelty (BERT): 0.5265048419434724
- Combined Prediction Score: 0.4927551628127348
- Mean Citation Score: 272.551514
- Max Citation Score: 322.8265
- Similarity Product: 244.3165755069852

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test